An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
As a urologist I'm seeing teenagers with bladders so damaged they need the kind of major reconstructive surgery I'd normally ...
What began as a late-night medical emergency for Alfred Ogene has turned into weeks of pain, confusion and lasting injury, ...
Discover how Abu Dhabi's Sheikh Shakhbout Medical City transformed the life of chef Mandhish Gomez, who endured over 20 years ...
Our conference coverage featured updates on clinical trials testing new treatments for NSCLC, bladder cancer, and breast cancer. Highlights of the conference coverage from the 2025 European Society of ...
He mentioned advanced procedures such as URS, ICPL, laser therapy, PCNL and RIRS, adding that kidney or bladder tumors and ...
The Vancouver Sun on MSN
This made-in-B.C. preventive surgery lowers ovarian cancer risk
Opportunistic salpingectomy, or the removal of fallopian tubes in women already undergoing another abdominal or gynecological ...
A woman who had to lie on the floor of the A&E department at South West Acute Hospital (SWAH) to get relief has said it is “ridiculous” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback